MedPath

LYPHOLYTE MULTI-ELECTROLYTE CONC INJ

LYPHOLYTE MULTI-ELECTROLYTE CONC INJ

Discontinued
DIN Number

01944940

Drug Class

Human

Market Date

Dec 31, 1991

Company
HC

lyphomed, division of fujisawa canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01944940
AIG Number0610335002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA30 COMBINATIONS OF ELECTROLYTES
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (6)

CALCIUM ACETATEActive
Strength: 22 MG / ML
Monograph: CALCIUM ACETATE
MAGNESIUM ACETATEActive
Strength: 43 MG / ML
Monograph: MAGNESIUM ACETATE
POTASSIUM ACETATEActive
Strength: 34.5 MG / ML
Monograph: POTASSIUM ACETATE
POTASSIUM CHLORIDEActive
Strength: 125 MG / ML
Monograph: POTASSIUM CHLORIDE
SODIUM ACETATEActive
Strength: 135 MG / ML
Monograph: SODIUM ACETATE
SODIUM GLUCONATEActive
Strength: 55 MG / ML
Monograph: SODIUM GLUCONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.